相关实验视频

Updated: May 9, 2025

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

细胞外囊泡在败血症管理中的治疗潜力

Laifa Kong¹, Qigang Huang¹, Jianghua Cheng¹

¹Department of Obstetrics and Gynecology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua Municipal Central Hospital, Jinhua, Zhejiang Province,China.

DNA and cell biology

|May 5, 2025

概括

细胞外囊泡 (EVs) 显示出治疗败血症的希望,这是一个危及生命的疾病. 这些纳米级生物载体提供免疫调节和药物输送,可能改善患者的治疗结果并降低死亡率.

科学领域:

免疫学免疫学免疫学
纳米医学是一种纳米医学.
关键护理医学关键护理医学

背景情况:

败血症是对感染的关键系统性炎症反应,尽管目前的治疗方法,死亡率很高.
现有的抗生素和支持性护理等疗法在完全治疗败血症方面存在局限性.
细胞外囊泡 (EVs) 正因其生物功能而成为一种新的治疗方式.

研究的目的:

审查细胞外囊泡 (EVs) 在败血症管理中的治疗潜力.
探索EVs在败血症治疗中的内在和药物输送能力.
突出EVs作为治疗败血症的有前途的创新方法.

主要方法:

在败血症模型中研究细胞外囊泡的研究文献综述.
分析各种EVs的免疫调节和组织再生特性.
检查EV作为药物输送系统用于协同性败血症治疗.

主要成果:

在临床前的败血症模型中,EV显示出显著的治疗效果.
电动车具有固有的免疫调节能力,对败血症有益.
电动汽车可以被设计为有针对性的输送车辆,以提高药物疗效.

结论:

细胞外囊泡疗法为败血症治疗提供了一种新的动态策略.
电动汽车既提供了内在的治疗效益,也提供了针对药物输送的平台.
对基于EV的治疗方法的进一步研究对于推进败血症管理至关重要.

关键词:

药物装载技术技术药物装载技术细胞外囊泡中的细胞外囊泡.免疫调节免疫调节免疫调节这是一种血症.

更多相关视频

Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines

Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines

Published on: February 17, 2023

Evaluation of the Storage Stability of Extracellular Vesicles

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...